This resulted in a 10-year cumulative incidence of 18.9% (95% CI: 6.9–51.1) for those with both MBL and CHIP-CLL compared to 0.9% (95% CI: 0.6–1.2) in those with neither of these precursors. This evidence concerns the gene STUB1 and B-cell chronic lymphocytic leukemia.